GlobalData
GlobalData

Jonthan Brown

  • Home
  • Author: Jonthan Brown

Burberry better positioned to face COVID-19 thanks to digital expertise

Following today’s release of Burberry FY figures for 2019/20, Sofie Willmott, Lead Retail Analyst at GlobalData, a leading data and analytics company, comments: ‘‘Burberry’s full year performance was significantly impacted by the pandemic originating in its biggest market, APAC, however it is starting to see green shoots of recovery in this region and can leverage […]
Read more

Medtronic’s gains in respiratory business not enough to prevent losses in revenues due to COVID-19

Following Medtronic Q4 financial results; Azadeh Laffafian, PhD, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “Many segments of the medical devices market have been negatively impacted by the COVID-19 pandemic. The main culprit has been the deferral of elective and non-urgent procedures leading to a reduction in the […]
Read more

Over 30% of UK consumers plan to spend more locally post-COVID-19

Local retailers are set for a much needed post-lockdown boost as almost one in three British consumers say they will visit local shops more frequently than they did before the crisis*, says GlobalData, a leading data and analytics company. Sofie Willmott, Lead Retail Analyst at GlobalData, comments: “The COVID-19 pandemic has reignited the importance of […]
Read more

Sunovian’s novel sublingual formulation will address major unmet need in highly competitive Parkinson’s treatment market

Following the recent news that Sunovion Pharmaceuticals has received Food and Drug Administration (FDA) approval for Kynmobi (apomorphine), a novel sublingual film for the acute treatment of OFF episodes in patients with Parkinson’s disease (PD); Sarah Elsayed, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on the opportunities and challenges […]
Read more

Carluccio’s still needs to withstand COVID-19 crisis as restaurant industry is set to experience sharp downturn

Following today’s news (Friday 22 May) that British billionaire Ranjit Singh Boparan bought the Carluccio’s brand of restaurants, along with 31 other outlets; Hakan Demirci, Consumer Analyst at GlobalData, a leading data and analytics company, offers his view on the chains current challenges: “News that Carluccio’s has been saved by the billionaire Boparan may be […]
Read more

COVID-19 adds to M&A rationale in autos

Following the news that Exor NV – Fiat-Chrysler’s (FCA’s) largest investor – has confirmed the timing for the proposed FCA-PSA merger for completion by early 2021 as initially announced; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “The COVID-19 crisis will be adding pressures for corporate restructuring in […]
Read more

Label update to encourage prescription of anti-diabetic drugs outside the SGLT-2 inhibitor class

Following the FDA’s safety review on sodium glucose-transporter-2 (SGLT-2) inhibitors, a label update was issued stating that patients undergoing any scheduled surgery should discontinue treatment up to 3-4 days in advance of surgery. This label update is expected to influence physician decisions, encouraging the prescription of anti-diabetic drugs outside the SGLT-2 inhibitor class, according to GlobalData, a […]
Read more

Top 25 retailers by market capitalization in Q1 2020 see QOQ decline with exception of Amazon and JD Sports, says GlobalData

Most of the top 25 publicly traded global retailers by market capitalization (MCap) reported quarter-on-quarter (QoQ) declines for the first quarter (Q1) ending 31 March 2020, with Amazon and JD.com being exceptions, according to GlobalData, a leading data and analytics company. Keshav Kumar Jha, Company Profiles Analyst at GlobalData, comments: “Amazon’s share price recovered by […]
Read more

Future for independent hoteliers remains uncertain

Due to the impact of COVID-19, major hotel chains such as Wyndham, Marriott, Choice, Hilton, IHG and Accor are set to expand at an even quicker rate when travel resumes, creating even more uncertainty for independent hoteliers, says GlobalData, a leading data and analytics company. These companies accounted for more than half of global branded […]
Read more

Lockheed Martin adopts schedule and shift changes amongst COVID-19 mitigation measures

Following the news that Lockheed Martin is slowing F-35 production as COVID-19 disrupts its supply chain; Anthony Endresen, Aerospace and Defense Analyst at GlobalData, a leading data and analytics company, offers his view on the situation; “Lockheed Martin is adopting several measures to mitigate the delays imposed by COVID-19. These include adjusting work schedules and […]
Read more

Patients treated for hospital delirium will increase due to COVID-19

An estimated 70–80% of ventilated patients will experience ICU delirium, which causes patients to enter a confused state and can lead to long-term cognitive impairments and memory deficits. GlobalData, therefore, expects to see an increase in the administration of pharmacological treatments for ICU delirium as the COVID-19 outbreak continues. Johanna Swanson, Product Manager at GlobalData comments: […]
Read more

Ibudilast clinical trial launched for ARDS in COVID-19

Yale University launched a clinical trial of ibudilast (MN-166) to assess it as a treatment for COVID-19 patients with acute respiratory distress syndrome (ARDS), a cause of death in COVID-19 patients. The drug has anti-inflammatory and neuroprotective effects and suppresses the production of pro-inflammatory cytokines. It has approval in Japan for the treatment of asthma, […]
Read more

Vodafone expects SME hit but looks to automation, 5G, and IoT to respond to COVID-19 crisis

Following the announcement of Vodafone’s FY2019/20 financial results and COVID-19 guidance;  Gary Barton, Principal Analyst atGlobalData, a leading data and analytics company, offers his view: “Vodafone’s increase in momentum is, in most European markets, a slowing in decline of service revenues rather than increased organic revenue growth. The upside is that the provider can point […]
Read more
1 16 17 18 19 20 37